BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36846002)

  • 21. Insights into the prognostic value and immunological role of CD74 in pan-cancer.
    Liu Z; Chen M; Zheng W; Yuan S; Zhao W
    Discov Oncol; 2024 Jun; 15(1):222. PubMed ID: 38861249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ablation of the tumor suppressor histidine triad nucleotide binding protein 1 is protective against hepatic ischemia/reperfusion injury.
    Martin J; Romanque P; Maurhofer O; Schmitter K; Hora C; Ferrand G; Dufour JF
    Hepatology; 2011 Jan; 53(1):243-52. PubMed ID: 21140474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hint1 inhibits growth and activator protein-1 activity in human colon cancer cells.
    Wang L; Zhang Y; Li H; Xu Z; Santella RM; Weinstein IB
    Cancer Res; 2007 May; 67(10):4700-8. PubMed ID: 17510397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ANXA2 is a potential biomarker for cancer prognosis and immune infiltration: A systematic pan-cancer analysis.
    Ning Y; Li Y; Wang H
    Front Genet; 2023; 14():1108167. PubMed ID: 36713082
    [No Abstract]   [Full Text] [Related]  

  • 25. Histidine triad nucleotide-binding protein 1 (HINT1) regulates Ca(2+) signaling in mouse fibroblasts and neuronal cells via store-operated Ca(2+) entry pathway.
    Linde CI; Feng B; Wang JB; Golovina VA
    Am J Physiol Cell Physiol; 2013 Jun; 304(11):C1098-104. PubMed ID: 23576580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histidine Triad Nucleotide-Binding Protein 1 Improves Critical Limb Ischemia by Regulating Mitochondrial Homeostasis.
    Gao T; Cheng S; Lu H; Li X; Weng X; Ge J
    Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Pan-Cancer Crosstalk Between the
    Xie R; Yuan M; Jiang Y
    Front Cell Dev Biol; 2022; 10():790947. PubMed ID: 35309935
    [No Abstract]   [Full Text] [Related]  

  • 28. A systemic pan-cancer analysis of MPZL3 as a potential prognostic biomarker and its correlation with immune infiltration and drug sensitivity in breast cancer.
    Huang R; Li L; Wang Z; Shen K
    Front Oncol; 2022; 12():901728. PubMed ID: 35965540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis.
    Liu P; Wang X; Pan L; Han B; He Z
    Front Immunol; 2022; 13():901784. PubMed ID: 35720327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of
    Sun L; Liu P; Liu F; Zhou Y; Chu Z; Li Y; Chu G; Zhang Y; Wang J; Dang YH
    Brain Behav; 2017 Oct; 7(10):e00831. PubMed ID: 29075577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Value and Immunological Role of MORF4-Related Gene-Binding Protein in Human Cancers.
    Chai D; Zhang L; Guan Y; Yuan J; Li M; Wang W
    Front Cell Dev Biol; 2021; 9():703415. PubMed ID: 34660575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hint1 is a haplo-insufficient tumor suppressor in mice.
    Li H; Zhang Y; Su T; Santella RM; Weinstein IB
    Oncogene; 2006 Feb; 25(5):713-21. PubMed ID: 16186798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The intracellular domain of teneurin-1 induces the activity of microphthalmia-associated transcription factor (MITF) by binding to transcriptional repressor HINT1.
    Schöler J; Ferralli J; Thiry S; Chiquet-Ehrismann R
    J Biol Chem; 2015 Mar; 290(13):8154-65. PubMed ID: 25648896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of
    Cheng L; Zou X; Wang J; Zhang J; Mo Z; Huang H
    Front Surg; 2022; 9():1117307. PubMed ID: 36713654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy.
    Hu J; Qiu D; Yu A; Hu J; Deng H; Li H; Yi Z; Chen J; Zu X
    Front Oncol; 2021; 11():607224. PubMed ID: 34026603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic and immunological role of Ras-related protein Rap1b in pan-cancer.
    Cui G; Wang C; Lin Z; Feng X; Wei M; Miao Z; Sun Z; Wei F
    Bioengineered; 2021 Dec; 12(1):4828-4840. PubMed ID: 34346294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RecQ mediated genome instability 2 (
    Wei W; Ying X; Chen L; Sun Q; Lu X; Xia Y; Xu R; Zhu Z; Zhang D; Tang Q; Li L; Xie J; Yu H
    Aging (Albany NY); 2022 May; 14(9):4107-4136. PubMed ID: 35552266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Histidine triad nucleotide-binding protein 1 and human diseases].
    Dang YH; Liu ZW; Chen F; Guo K; Wang JB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Aug; 36(4):454-60. PubMed ID: 25176218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Family history of gastric cancer correlates with decreased expression of HINT1 tumor suppressor gene in gastric mucosa of dyspeptic patients.
    Zuk K; Peczek L; Stec-Michalska K; Medrek M; Nawrot B
    Oncol Lett; 2012 Jan; 3(1):219-223. PubMed ID: 22740884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.